Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 2,482 | 2,178 | 1,795 | 1,852 | 2,163 |
| Gross Profit | 2,482 | 2,178 | 1,795 | 1,852 | 2,163 |
| Operating Expenses | 10,094 | 8,688 | 8,567 | 7,431 | 6,612 |
| Operating Income | -7,612 | -6,510 | -6,772 | -5,579 | -4,449 |
| Other Income | -35,987 | -39,180 | -27,463 | -32,959 | -24,825 |
| Pre-tax Income | -43,599 | -45,690 | -34,235 | -38,538 | -29,274 |
| Net Income Continuous | -43,599 | -45,690 | -34,235 | -38,538 | -29,274 |
| Net Income | $-43,599 | $-45,690 | $-34,235 | $-38,538 | $-29,274 |
| EBITDA(a) | $-7,612 | $-6,510 | $-6,772 | $-5,579 | $-4,449 |